Enjoy complimentary customisation on priority with our Enterprise License!
The Global 3D Bioprinting Market size is estimated to grow at a CAGR of 19.94% between 2022 and 2027. The market size is forecast to increase by USD 2,015.81 million. The growth of the market depends on several factors, including the rising cost efficiency and enhanced productivity, the advancements in 3D bioprinting technology, and the increased demand for personalized or customized orthopaedic devices. Challenges such as high initial costs to set up a 3D printing facility, inability of researchers to combine vascular supply in printed tissues and organs, and limited availability of suitable biomaterials might hamper the growth of the market. Nevertheless, trends such as developments in scaffold-free bioprinting, biofabrication of complex tissues, and the rising focus on R and D of 3D bioprinting will boost the growth of the market.
This 3d bioprinting market report extensively covers 3D bioprinting market segmentation by application (human tissue and organ generation, medical testing, dental, prosthetics, and others), solution (3d bioprinters, bioprinting materials, and services and ancillary equipment), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Request Free Sample
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The advancements in 3D bioprinting technology are notably driving 3D bioprinting market growth. The global 3D bioprinting market is being significantly fueled by the ongoing improvements in 3D bioprinting technologies, such as better bio-ink formulations, printing methods, and tissue engineering strategies. These developments allow the creation of more complex and functional tissue structures, which will transform the field of regeneration medicine. The new formulations of bio-inks improve cell survival, encourage tissue fusion and make it easier to create structures that are personalized for each patient.
Moreover, improvements in printing methods, including the use of numerous printheads or extruders, allow for the simultaneous deposition of several cell types and materials, producing more precise and intricate tissue constructs. Moreover, Innovative approaches to tissue engineering, e.g. bioprinting on pre-pasteurised substrates or the application of thin fibrin networks, offer exciting options for building strong and efficient tissues. Consequently, the emergence of 3D bioprint technology is promoting market growth and pushing boundaries for regenerative medicine and personalized health care by increasing the likelihood that tissues or organs will be developed in accordance with both physiological and therapeutic needs. Owing to all these factors, the market in focus is expected to witness significant growth during the forecast period.
The fabrication of complex tissues is a primary trend in the 3D bioprinting market share. The focus on fabricating complex tissues and multi-organ complexes is a prominent trend in the global 3D bioprinting market. To create functioning tissues with complex structures, researchers are investigating the simultaneous printing of several cell types, extracellular matrix, and growth hormones.
The development of multi-organ complexes and complex tissues that can be printed holds great promise for the future of personalized healthcare and regenerative medicine. In view of that fact, this trend is anticipated to have a strong impact on the market over the forecast period and will be instrumental in its growth.
The inability of researchers to combine vascular supply in printed tissues and organs is a major challenge in the 3D bioprinting market. Although the 3D bioprinting market has witnessed major breakthroughs over the years, it is far from bioprinting a fully functional organ or tissue for transplant. The researchers are successful in bioprinting parts of an organ or tissue that has cells fully capable of performing their dedicated functions. However, they have not been able to combine vascular veins in the printed organs, though they can be printed separately.
The bioprinted product needs the vascular vein network and the necessary blood flow in it to work. Without the vascular system, the thickness of the tissue is limited. Growth in the focus market would be limited until an intact organ has been developed and readiness for transplantation is achieved. It does not envisage that this technology will be commercially available to end users in the future. Consequently, it is expected that a challenge to the growth of the market in focus over the forecast period will be researchers' failure to combine blood vessel supply for printing tissues and organs.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global 3D Bioprinting Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
3D Bioprinting Solutions - The company offers 3D bioprinting such as Fabion 2 and Viscoll.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the human tissue and organ generation segment will be significant during the forecast period. Human tissue and organ generation can reduce the waiting period for patients who need organ donors. The other benefit of using 3D-bioprinted organs is that the chances of the patient's body rejecting the implant are reduced to a bare minimum. Organ implants from donors are often rejected by the patient's body leading to complications post-implantation.
Get a glance at the market contribution of various segments View the PDF Sample
This human tissue and organ generation shows a gradual increase in the market share of USD 221.27 million in 2017 and continue to grow by 2021. Although the technology for printing organs is still in the developmental stage, laboratories, and research organizations have successfully developed a human kidney. However, bioprinted organs were not ready for human trials till 2017. The demand for 3D bioprinting in the Human tissue and organ generation application is expected to increase and hence drive the growth of the market in focus during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 31% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America accounted for the largest revenue share of the global 3D bioprinting market in 2022. The US and Canada are the significant revenue contributors to the market in focus in North America. The growth of the market in focus in the region can be attributed to improved healthcare infrastructure, high adoption of 3D bioprinting technologies in healthcare facilities, and the presence of established companies.
The rising number of COVID-19 cases negatively impacted the growth of the market in the region in 2020. However, the initiation of mass COVID-19 vaccination drives and the restoration of supply chain operations for 3D bioprinters revived the growth of the regional market in 2021. The regional market was also further driven by the resumption of elective surgery in 2021 and onwards, as well as increased regional economic growth. In addition, the regional 3D bioprinting market is anticipated to grow significantly over the forecast period driven by the growing adoption of automation in 3D technology and increased healthcare expenditure.
The 3d bioprinting market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
3D Bioprinting Market Scope |
|
Report Coverage |
Details |
Page number |
170 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 19.94% |
Market growth 2023-2027 |
USD 2015.81 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
19.82 |
Regional analysis |
North America, Europe, Asia, and Rest of the World (ROW) |
Performing market contribution |
North America at 31% |
Key countries |
US, Canada, Germany, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Solution
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.